LEADER 03776nam 2200757Ia 450 001 9910777491203321 005 20230421044824.0 010 $a0-19-772136-2 010 $a1-280-52717-X 010 $a0-19-535879-1 010 $a1-4294-0649-6 035 $a(CKB)1000000000415173 035 $a(EBL)271186 035 $a(OCoLC)227038249 035 $a(SSID)ssj0000123164 035 $a(PQKBManifestationID)11142173 035 $a(PQKBTitleCode)TC0000123164 035 $a(PQKBWorkID)10027403 035 $a(PQKB)10836418 035 $a(Au-PeEL)EBL271186 035 $a(CaPaEBR)ebr10142183 035 $a(CaONFJC)MIL52717 035 $a(OCoLC)936850237 035 $a(MiAaPQ)EBC271186 035 $a(EXLCZ)991000000000415173 100 $a19940802d1995 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aClause structure and language change$b[electronic resource] /$fedited by Adrian Battye, Ian Roberts 210 $aNew York $cOxford University Press$d1995 215 $a1 online resource (380 p.) 225 1 $aOxford studies in comparative syntax 300 $aBased on material presented at the 1st Generative Diachronic Syntax Conference which was held at the University of York, Apr. 1990. 311 $a0-19-508633-3 311 $a0-19-508632-5 320 $aIncludes bibliographical references. 327 $aContents; 1. Introduction; 2. ""Why UG Needs a Learning Theory: Triggering Verb Movement""; 3. ""Two Types of Verb Second in the History of Yiddish""; 4. ""The Locus of Verb Movement in Non-Asymmetric Verb-Second Languages: The Case of Middle French""; 5. ""Evidence for a Verb-Second Phase in Old Portuguese""; 6. ""Indo-European Origins of Germanic Syntax""; 7. ""On the Decline of Verb Movement to Comp in Old and Middle French""; 8. ""The Loss of Verb Second in English and French""; 9. ""Verb Second, Pro-drop, Functional Projections and Language Change"" 327 $a10. ""Null Subjects in Verb-First Embedded Clauses in Philippe de Vigneulles' Cent Nouvelles Nouvelles""11. ""The Diachronic Development of Subject Clitics in North Eastern Italian Dialects""; 12. ""Complement Clitics in Medieval Romance: the Tobler-Mussafia Law""; 13. ""Cases of Verb Third in Old High German"" 330 $aA collection of previously unpublished papers on a specific topic in historical linguistics - clause structure. These papers testify to the recent renewal of interest in diachronic syntax, a consequence of the new emphasis on comparative issues in the principles and parameters framework. 410 0$aOxford studies in comparative syntax. 606 $aGrammar, Comparative and general$xClauses$vCongresses 606 $aGrammar, Comparative and general$xSyntax$vCongresses 606 $aLinguistic change$vCongresses 606 $aPrinciples and parameters (Linguistics)$vCongresses 606 $aGrammar, Comparative and general$xVerb$vCongresses 606 $aGrammar, Comparative and general$xClitics$vCongresses 615 0$aGrammar, Comparative and general$xClauses 615 0$aGrammar, Comparative and general$xSyntax 615 0$aLinguistic change 615 0$aPrinciples and parameters (Linguistics) 615 0$aGrammar, Comparative and general$xVerb 615 0$aGrammar, Comparative and general$xClitics 676 $a415 701 $aBattye$b Adrian$0220823 701 $aRoberts$b Ian G$0168980 712 12$aGenerative Diachronic Syntax Conference$d(1st :$f1990 :$eUniversity of York) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910777491203321 996 $aClause structure and language change$93829345 997 $aUNINA LEADER 01699oam 2200529zu 450 001 9910829984903321 005 20210908061907.0 010 $a3-527-62660-3 035 $a(CKB)1000000000820643 035 $a(SSID)ssj0000354648 035 $a(PQKBManifestationID)11259190 035 $a(PQKBTitleCode)TC0000354648 035 $a(PQKBWorkID)10315913 035 $a(PQKB)10807519 035 $a(PPN)15252553X 035 $a(EXLCZ)991000000000820643 100 $a20160829d2009 uy 101 0 $aeng 181 $ctxt 182 $cc 183 $acr 200 00$aPost-translational modification of protein biopharmaceuticals 210 31$a[Place of publication not identified]$cWiley VCH$d2009 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a3-527-32074-1 606 $aProtein Processing, Post-Translational 606 $aGlycosylation 606 $aProtein Engineering$xmethods 606 $aProteins$xanalysis 606 $aBiopharmaceutics 606 $aBiotechnology$xmethods 606 $aPharmacy, Therapeutics, & Pharmacology$2HILCC 606 $aHealth & Biological Sciences$2HILCC 615 12$aProtein Processing, Post-Translational. 615 12$aGlycosylation. 615 22$aProtein Engineering$xmethods. 615 22$aProteins$xanalysis. 615 22$aBiopharmaceutics. 615 22$aBiotechnology$xmethods. 615 7$aPharmacy, Therapeutics, & Pharmacology 615 7$aHealth & Biological Sciences 702 $aWalsh$b Gary 801 0$bPQKB 906 $aBOOK 912 $a9910829984903321 996 $aPost-translational modification of protein biopharmaceuticals$94014475 997 $aUNINA LEADER 01199cam0-2200385---450 001 990006104870203316 005 20240223085735.0 035 $a000610487 035 $aUSA01000610487 035 $a(ALEPH)000610487USA01 035 $a000610487 100 $a20151210f1970----km-y0itay5003----ba 101 0 $aita 102 $aIT 105 $a||||||||001yy 200 1 $aBasso Medioevo$fGiuseppe Martini 210 $aMilano$cMarzorati$d[1970?] 215 $a[79]-471 p.$d24 cm 300 $aEstratto da: La storiografia italiana negli ultimi vent'anni, vol. 1 300 $aTitolo della copertina 606 0 $aMedioevo$xStoriografia italiana$zSec. 20$2BNCF 676 $a940.1072 700 1$aMARTINI,$bGiuseppe$f<1908-1979>$0191765 801 0$aIT$bsalbc$gISBD 912 $a990006104870203316 951 $aFC M 2827$b3551 FCil$cFC M$d382370 959 $aBK 969 $aFCIL 979 $aRIVELLI$b90$c20151210$lUSA01$h1546 979 $aRIVELLI$b90$c20151210$lUSA01$h1550 979 $aRIVELLI$b90$c20151210$lUSA01$h1600 979 $aRIVELLI$b90$c20151210$lUSA01$h1600 979 $aRIVELLI$b90$c20151210$lUSA01$h1602 996 $aBasso medioevo$91383734 997 $aUNISA